Page last updated: 2024-08-17

adenosine diphosphate and iloprost

adenosine diphosphate has been researched along with iloprost in 52 studies

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-199022 (42.31)18.7374
1990's21 (40.38)18.2507
2000's3 (5.77)29.6817
2010's5 (9.62)24.3611
2020's1 (1.92)2.80

Authors

AuthorsStudies
Ashby, B; Dangelmaier, C; Daniel, J; Selak, MA; Smith, JB1
Buerke, M; Darius, H; Dieterich, HA; Meyer, J1
Keen, M; Kelly, E; MacDermot, J; Nobbs, P1
Mollace, V; Moore, A; Radziszewski, W; Salvemini, D; Vane, J; Willoughby, D1
Buzzi, E; Colao, C; Leoncini, G; Maresca, M; Mazzei, M1
Galli, C; Grassi, G; Lograno, MD; Marangoni, F; Medini, L; Mosconi, C1
Abi-Younes, SA; Ayers, ML; Myers, AK1
Bull, H; Machin, SJ; Mackie, IJ; Yardumian, DA1
Colli, S; Maderna, P; Paoletti, R; Sirtori, C; Tremoli, E1
Kutti, J; Wadenvik, H1
Skuballa, W; Vorbrüggen, H2
Brennan, EC; Bull, H; Machin, SJ; Mackie, IJ; Yardumian, DA1
Addonizio, VP; Cottrell, ED; Fisher, CA; Kappa, JR; Reiser, HJ; Sinha, AK1
Addonizio, VP; Fisher, CA; Kappa, JR; Musial, J1
Linch, DC; Machin, SJ; O'Flynn, K; Yardumian, DA1
Barbenel, JC; Belch, JJ; Forbes, CD; Lowe, GD; Saniabadi, AR1
Clarke, BF; Collier, A; Jones, RL; Matthews, DM; Tymkewycz, PM1
Fitscha, P; Sinzinger, H; Tiso, B1
Cohen, H; Machin, SJ; Mackie, IJ; Neild, GH; Patel, R1
Faul, C; Jaschonek, K; Renn, W; Schmidt, H1
Frojmovic, MM; Pedvis, LG; Wong, T1
Stürzebecher, S; Witt, W1
Lapetina, EG; Molina y Vedia, L; Nolan, RD1
Macagni, A; Pozza, G; Vicari, AM1
Maass, B; Müller, B; Skuballa, W; Stürzebecher, S1
Barbenel, JC; Belch, JJ; Forbes, CD; Lowe, GD; Prentice, CR; Saniabadi, AR1
Adaikan, PG; Karim, SM; Kottegoda, SR; Lau, LC; Tai, MY1
Jones, R; Machin, SJ; Mackie, IJ1
Brassard, CL; Buchanan, JO; Gougoutas, JZ; Malley, MF; Martin, SW; Meanwell, NA; Romine, JL; Rosenfeld, MJ; Trehan, AK; Wright, JJ1
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Mularoni, E; Trovati, M1
Braun, M; Hohlfeld, T; Scharnowski, F; Schrör, K1
Bernabei, A; Edmunds, LH; Gikakis, N; Kowalska, MA; Niewiarowski, S1
Andrews, R; Heptinstall, S; May, JA; Vickers, J1
Armstrong, R; Heptinstall, S; Lösche, W; May, JA1
Hohlfeld, T; Schrör, K; Strobach, H; Weber, AA1
Abiko, Y; Ichihara, K; Yamamoto, K1
Grünberg, B; Siess, W1
Cohen, H; Enayat, ZE; Flores, NA; Goulielmos, NV; Sheridan, DJ1
Chinellato, A; Doni, MG; Meggiato, C; Padoin, E; Ragazzi, E1
Ayaz, S; Katircioğlu, SF; Saritaş, Z; Ulus, AT; Yamak, B; Yücel, D1
Glenn, JR; Heptinstall, S1
Doni, MG; Picunio, S; Simioni, M1
Akkerman, JW; den Dekker, E; Gorter, G; Heemskerk, JW; van der Vuurst, H1
Kobzar, G; Mardla, V; Samel, N1
Buerkle, MA; Conzen, P; Krötz, F; Lehrer, S; Pohl, U; Sohn, HY1
Anfossi, G; Bonomo, K; Cavalot, F; De Salve, A; Del Mese, P; Doronzo, G; Mattiello, L; Russo, I; Traversa, M; Trovati, M1
Brunner, KP; Kobsar, AL; Koessler, J; Rajkovic, MS; Steigerwald, U; Walter, U1
Beck, F; Buhs, S; Geiger, J; Gerull, H; Nollau, P; Schweigel, H; Sickmann, A; Walter, U1
Dhillon, K; Dovlatova, N; Fox, SC; Glenn, JR; Heptinstall, S; White, AE1
Beck, F; Burkhart, JM; Dell'Aica, M; Fufezan, C; Gambaryan, S; Geiger, J; Heemskerk, JW; Jurk, K; Loroch, S; Mattheij, NJ; Mindukshev, I; Pötz, O; Sickmann, A; Solari, FA; Walter, U; Zahedi, RP1
Costa, JL; Leonardi, GR; Lescano, CH; Mazetto, B; Monica, FZ; Orsi, FA1

Trials

3 trial(s) available for adenosine diphosphate and iloprost

ArticleYear
Iloprost in peripheral vascular disease--platelet function and clinical outcome.
    Progress in clinical and biological research, 1987, Volume: 242

    Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Agents; Clinical Trials as Topic; Collagen; Epoprostenol; Humans; Iloprost; Male; Pain; Platelet Aggregation; Random Allocation; Vascular Diseases

1987
Inhibition of platelet aggregation by transdermal glyceryl trinitrate.
    British heart journal, 1994, Volume: 72, Issue:6

    Topics: Adenosine Diphosphate; Administration, Cutaneous; Cross-Over Studies; Humans; Iloprost; Nitric Oxide; Nitroglycerin; Platelet Aggregation; Platelet Function Tests; Prospective Studies

1994
In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin.
    Obesity (Silver Spring, Md.), 2010, Volume: 18, Issue:4

    Topics: Adenosine Diphosphate; Adipose Tissue; Adult; Blood Platelets; Cyclic AMP; Cyclic GMP; Diet, Reducing; Endothelium, Vascular; Epoprostenol; Female; Humans; Iloprost; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Obesity, Abdominal; Platelet Activation; Platelet Aggregation Inhibitors; Weight Loss

2010

Other Studies

49 other study(ies) available for adenosine diphosphate and iloprost

ArticleYear
Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
    The Biochemical journal, 1992, May-01, Volume: 283 ( Pt 3)

    Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Collagen; Cyclic AMP; Fluorescent Dyes; Fura-2; Humans; Iloprost; Platelet Adhesiveness; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Serotonin; Signal Transduction; Thrombin

1992
Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprost.
    Agents and actions. Supplements, 1992, Volume: 37

    Topics: Adenosine Diphosphate; Adenylyl Cyclases; Animals; Collagen; Cyclic AMP; Drug Synergism; Enzyme Activation; Humans; Iloprost; Imidazoles; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rats; Rats, Inbred Strains

1992
Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.
    British journal of pharmacology, 1990, Volume: 99, Issue:2

    Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Line; Epoprostenol; GTP-Binding Proteins; Hybrid Cells; Iloprost; Kinetics; Mice; Morphine; Neuroblastoma; Phosphorus Radioisotopes; Receptors, Epoprostenol; Receptors, Prostaglandin; Sodium Fluoride

1990
Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation.
    European journal of pharmacology, 1991, Jun-18, Volume: 199, Issue:1

    Topics: Adenosine Diphosphate; Biphenyl Compounds; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Free Radicals; Humans; Iloprost; In Vitro Techniques; Leukocytes; NADH, NADPH Oxidoreductases; Nitroprusside; Onium Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin

1991
Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
    Cell biochemistry and function, 1991, Volume: 9, Issue:2

    Topics: Adenosine Diphosphate; Adenylyl Cyclases; Chromones; Colforsin; Collagen; Cyclic AMP; Humans; Iloprost; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thrombin; Thromboxane A2

1991
Vascular eicosanoids and platelet-aortic wall interactions in spontaneously hypertensive rats.
    European journal of pharmacology, 1991, Sep-24, Volume: 202, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Aorta; Blood Platelets; Collagen; Hypertension; Iloprost; Male; Perfusion; Platelet Aggregation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane B2

1991
Mechanism of ethanol-induced aggregation in whole blood.
    Thrombosis research, 1991, Sep-01, Volume: 63, Issue:5

    Topics: Adenosine Diphosphate; Animals; Apyrase; Collagen; Ethanol; Female; Hemolysis; Humans; Iloprost; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains

1991
Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1985, Volume: 13

    Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Platelets; Cardiovascular Agents; Collagen; Epoprostenol; Fingers; Humans; Iloprost; Ischemia; Male; Middle Aged; Platelet Aggregation; Scleroderma, Systemic; Time Factors

1985
Control of human and animal platelet aggregation by a new prostacyclin analog.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1985, Volume: 13

    Topics: Adenosine Diphosphate; Animals; Cardiovascular Agents; Collagen; Dose-Response Relationship, Drug; Epinephrine; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation; Rabbits; Rats

1985
Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Acta haematologica, 1985, Volume: 73, Issue:4

    Topics: Adenosine Diphosphate; Adult; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation

1985
Synthesis of ZK-96,480: a chemically and metabolically stable potent prostacyclin analogue.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1985, Volume: 15

    Topics: Adenosine Diphosphate; Epoprostenol; Humans; Iloprost; Indicators and Reagents; Platelet Aggregation

1985
Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Haemostasis, 1986, Volume: 16, Issue:1

    Topics: Adenosine Diphosphate; Adult; Collagen; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Thromboxane B2; Time Factors

1986
Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:2

    Topics: Adenosine Diphosphate; Alprostadil; Animals; Coronary Circulation; Cyclic AMP; Epinephrine; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Platelet Aggregation; Rats; Thrombin

1987
Quantitation of platelet preservation with prostanoids during simulated bypass.
    The Journal of surgical research, 1987, Volume: 42, Issue:1

    Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Blood Specimen Collection; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Epinephrine; Epoprostenol; Extracorporeal Circulation; Humans; Iloprost; Platelet Count; Prostaglandins

1987
Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
    British journal of haematology, 1987, Volume: 65, Issue:3

    Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Epoprostenol; Heparin; Humans; Iloprost; Platelet Aggregation; Thrombin

1987
Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Haemostasis, 1987, Volume: 17, Issue:3

    Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Physiological Phenomena; Dose-Response Relationship, Drug; Epinephrine; Epoprostenol; Erythrocytes; Humans; Iloprost; Methods; Platelet Aggregation

1987
Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
    Diabetes research (Edinburgh, Scotland), 1987, Volume: 5, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Glucose; Blood Platelets; Cyclic AMP; Diabetes Mellitus, Type 1; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation; Thromboxane B2; Time Factors

1987
Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients.
    Thrombosis research, 1988, Jan-01, Volume: 49, Issue:1

    Topics: Adenine Nucleotides; Adenosine Diphosphate; Adult; Blood Platelets; Cyclosporins; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation; Thrombosis; Time Factors

1988
Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
    European journal of pharmacology, 1988, Mar-01, Volume: 147, Issue:2

    Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Blood Platelets; Cardiovascular Agents; Colforsin; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Kinetics; Phosphorus Radioisotopes; Ribose

1988
Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Thrombosis and haemostasis, 1988, Apr-08, Volume: 59, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Platelets; Dose-Response Relationship, Drug; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation

1988
The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Prostaglandins, 1988, Volume: 36, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Synergism; Epoprostenol; Fatty Acids, Unsaturated; Humans; Hydrazines; Iloprost; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides

1988
The effect of iloprost on the ADP-ribosylation of Gs alpha (the alpha-subunit of Gs).
    The Biochemical journal, 1989, Aug-01, Volume: 261, Issue:3

    Topics: Adenosine Diphosphate; Blood Platelets; Cell Membrane; Cell Membrane Permeability; Cholera Toxin; Epoprostenol; GTP-Binding Proteins; Humans; Iloprost; Poly(ADP-ribose) Polymerases

1989
Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1989, Volume: 21, Issue:11

    Topics: Adenosine Diphosphate; Adult; Collagen; Diabetes Mellitus, Type 1; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors

1989
Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Biomedica biochimica acta, 1984, Volume: 43, Issue:8-9

    Topics: Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Agents; Epoprostenol; Iloprost; Lidocaine; Platelet Aggregation; Rats; Rats, Inbred SHR; Reserpine

1984
Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1983, Volume: 11

    Topics: Adenosine Diphosphate; Cardiovascular Agents; Epoprostenol; Humans; Iloprost; Indicators and Reagents; Molecular Conformation; Platelet Aggregation; Prostaglandins; Structure-Activity Relationship

1983
The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Thrombosis and haemostasis, 1983, Oct-31, Volume: 50, Issue:3

    Topics: Adenosine Diphosphate; Cardiovascular Agents; Collagen; Epoprostenol; Humans; Iloprost; Platelet Aggregation; Platelet Count; Thrombin

1983
Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
    Thrombosis research, 1984, Feb-01, Volume: 33, Issue:3

    Topics: Adenosine Diphosphate; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Epoprostenol; Humans; Iloprost; Papio; Platelet Aggregation; Vasopressins

1984
Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
    Journal of clinical pathology, 1984, Volume: 37, Issue:8

    Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Collagen; Electrodes; Epoprostenol; Hematocrit; Humans; Iloprost; Platelet Aggregation; Platelet Count; Plethysmography, Impedance

1984
Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
    Journal of medicinal chemistry, 1993, Nov-26, Volume: 36, Issue:24

    Topics: Acetates; Adenosine Diphosphate; Binding, Competitive; Crystallization; Epoprostenol; Humans; Hydrogen Bonding; Iloprost; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship

1993
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Prostaglandins, leukotrienes, and essential fatty acids, 1993, Volume: 49, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adult; Arginine; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Epinephrine; Humans; Iloprost; Intracellular Fluid; Male; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Second Messenger Systems

1993
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:1

    Topics: Adenosine Diphosphate; Animals; Aortic Diseases; Arteriosclerosis; Biotransformation; Cholesterol, Dietary; Collagen; Cyclic AMP; Hypercholesterolemia; Iloprost; Indomethacin; Liver; Male; Platelet Aggregation; Rabbits; Signal Transduction; Thromboxane B2; Ticlopidine

1994
Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
    The Annals of thoracic surgery, 1995, Volume: 59, Issue:1

    Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cardiopulmonary Bypass; Colforsin; Cyclic AMP; Epinephrine; Humans; Iloprost; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Viper Venoms

1995
Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:2

    Topics: Adenosine Diphosphate; Amino Acid Sequence; Hirudins; Humans; Iloprost; Magnesium Chloride; Molecular Sequence Data; Molsidomine; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Streptokinase; Thromboxane A2

1995
Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Cholesterol; Collagen; Diet; Epoprostenol; Humans; Hypercholesterolemia; Iloprost; In Vitro Techniques; Male; Nafronyl; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thromboxanes

1993
Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.
    Molecular and cellular biochemistry, 1993, Feb-17, Volume: 119, Issue:1-2

    Topics: Adenosine Diphosphate; Animals; Dogs; Energy Metabolism; Female; Fructosediphosphates; Glucose-6-Phosphate; Glucosephosphates; Glycogen; Heart; Hemodynamics; Iloprost; Lactates; Male; Myocardial Ischemia; Phosphocreatine

1993
Phosphorylation of rap1B by protein kinase A is not involved in platelet inhibition by cyclic AMP.
    Cellular signalling, 1993, Volume: 5, Issue:2

    Topics: Adenosine Diphosphate; Collagen; Cyclic AMP; Epinephrine; GTP-Binding Proteins; Humans; Iloprost; Phorbol Esters; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinases; rab1 GTP-Binding Proteins; Signal Transduction; Vasopressins

1993
Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
    Cardiovascular research, 1995, Volume: 30, Issue:5

    Topics: Action Potentials; Adenosine Diphosphate; Animals; Arginine; Blood Platelets; Collagen; Epoprostenol; Guinea Pigs; Heart; Hemoglobins; Iloprost; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Platelet Aggregation Inhibitors; Vasodilator Agents

1995
Inhibition of platelet activation by MM-706, a stable carbacyclin analog, in the conscious rat.
    General pharmacology, 1997, Volume: 28, Issue:2

    Topics: Adenosine Diphosphate; Animals; Blood Pressure; Epoprostenol; Heart Rate; Iloprost; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Rats; Rats, Wistar

1997
Iloprost added to the cardioplegic solutions improves myocardial performance.
    Prostaglandins & other lipid mediators, 1998, Volume: 55, Issue:1

    Topics: Adenosine Diphosphate; Animals; Cardioplegic Solutions; Dogs; Hemodynamics; Iloprost; Myocardial Contraction; Myocardium; P-Selectin; Platelet Aggregation Inhibitors; Tumor Necrosis Factor-alpha; Vasodilator Agents

1998
Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
    Thrombosis and haemostasis, 1998, Volume: 80, Issue:2

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Colforsin; Cyclic AMP; Enzyme Activation; Humans; Iloprost; Magnesium; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Receptors, Purinergic P2; Reference Values

1998
Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat.
    Life sciences, 1999, Volume: 65, Issue:14

    Topics: Adenosine Diphosphate; Animals; Blood Pressure; Enzyme Induction; Heart Rate; Iloprost; Lipopolysaccharides; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Penicillamine; Platelet Activation; Platelet Count; Rats; Rats, Wistar; Thrombocytopenia

1999
Biogenesis of G-protein mediated calcium signaling in human megakaryocytes.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Calcium Signaling; Cattle; Cell Differentiation; Cells, Cultured; Fetal Blood; Flow Cytometry; Gene Expression Regulation, Developmental; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Protein alpha Subunits, Gs; Heterotrimeric GTP-Binding Proteins; Humans; Iloprost; Megakaryocytes; Platelet Activating Factor; Protein Isoforms; Proto-Oncogene Proteins; Stem Cells; Thrombin; Thrombopoietin

2001
Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Platelets, 2004, Volume: 15, Issue:5

    Topics: Adenosine Diphosphate; Adult; alpha-Tocopherol; Alprostadil; Blood Platelets; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Female; Humans; Iloprost; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Quercetin

2004
Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
    Circulation, 2004, Oct-05, Volume: 110, Issue:14

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Arterioles; Aspirin; Cells, Cultured; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Humans; Iloprost; Membrane Proteins; Mesocricetus; Nitrobenzenes; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Skin Window Technique; Sulfonamides; Thrombophilia; Umbilical Veins

2004
Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
    Platelets, 2010, Volume: 21, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Flow Cytometry; Humans; Iloprost; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Epoprostenol; Receptors, Purinergic P2Y12; Ticlopidine; Young Adult

2010
Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
    Proteomics, 2013, Volume: 13, Issue:6

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Blood Platelets; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Humans; Iloprost; Phosphorylation; Phosphotyrosine; Platelet Activation; Protein Processing, Post-Translational; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; src Homology Domains; Tandem Mass Spectrometry

2013
'VASPFix' for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists.
    Thrombosis and haemostasis, 2014, Mar-03, Volume: 111, Issue:3

    Topics: Adenosine; Adenosine Diphosphate; Alprostadil; Biomarkers, Pharmacological; Blood Platelets; Bucladesine; Cell Adhesion Molecules; Cells, Cultured; Clopidogrel; Cyclic AMP; Humans; Iloprost; Microfilament Proteins; Phosphoproteins; Phosphorylation; Piperazines; Platelet Aggregation; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Reproducibility of Results; Sensitivity and Specificity; Thiophenes; Thrombophilia; Ticlopidine

2014
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition.
    Blood, 2017, 01-12, Volume: 129, Issue:2

    Topics: Adenosine Diphosphate; Blood Platelets; Blotting, Western; Humans; Iloprost; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Proteomics; Signal Transduction

2017
Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y
    Journal of thrombosis and haemostasis : JTH, 2022, Volume: 20, Issue:7

    Topics: Adenosine Diphosphate; Antiphospholipid Syndrome; Blood Platelets; Cyclic AMP; Cyclic GMP; Humans; Iloprost; Nitroprusside; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction

2022